Aspect Biosystems is a biotechnology company pioneering the development of a novel category of cellular medicines designed to replace or restore biological function and deliver curative therapies for some of the most elusive diseases. Aspect is developing these bioengineered cellular medicines by applying its full-stack tissue therapeutic platform, which integrates proprietary AI-powered bioprinting technology, therapeutic cells, hypoimmune cell engineering, and advanced…
Saved company profile
Historical company information from a saved The Jobs API profile (LinkedIn/Crunchbase fields). It is not live-verified; figures may have changed. Missing values remain unknown.
Developing Bioprinted Tissue Therapeutics to transform how we treat some of the most elusive diseases.
Full company description
Aspect Biosystems is a biotechnology company pioneering the development of a novel category of cellular medicines designed to replace or restore biological function and deliver curative therapies for some of the most elusive diseases. Aspect is developing these bioengineered cellular medicines by applying its full-stack tissue therapeutic platform, which integrates proprietary AI-powered bioprinting technology, therapeutic cells, hypoimmune cell engineering, and advanced biomaterials. Aspect is advancing its therapeutic pipeline across multiple endocrine and metabolic diseases, including diabetes and rare endocrine disorders.
LinkedIn followers
28,490
People associated on LinkedIn
145
Reported office locations
2131 Manitoba St, Vancouver, British Columbia V5Y 0N7, CA
Business categories
Health Care
Biotechnology
Life Science
Artificial Intelligence (AI)
3D Printing
Other recorded names
Aspect Biosystems
Specialties
bioprinting
regenerative medicine
therapeutic development
and cell therapy
Profile identifies a recruitment agency
No
Reported total investment
252,846,526
Currency and observation date were not supplied; this is not a current valuation or a funding round.
Aspect Biosystems: Aspect Biosystems is a biotechnology company pioneering the development of a novel category of cellular medicines designed to replace or restore…
6+ YOECandidates need an M.S. or Ph.D. in chemical, bio or biomedical engineering or a related life science, plus 6 to 8+ years in cell therapy, bioprocess or biologics manufacturing. Strong GMP, DOE and hands-on process characterization experience is required.
Aspect Biosystems: Aspect Biosystems is a biotechnology company pioneering the development of a novel category of cellular medicines designed to replace or restore…
1+ YOECandidates need a diploma or BSc in a relevant field and at least one year of in vivo research or rodent handling experience. UBC animal care training and comfort working with rodents are preferred, and adaptability and teamwork are essential.
Aspect Biosystems: Aspect Biosystems is a biotechnology company pioneering the development of a novel category of cellular medicines designed to replace or restore…
1+ YOECandidates need a BSc or MSc in chemical, bio or biomedical engineering or a related life science, with 1-2+ years of biomanufacturing experience, ideally in cell therapy. They also need GMP and GDP knowledge, analytical skills and strong written and verbal communication.
Aspect Biosystems: Aspect Biosystems is a biotechnology company pioneering the development of a novel category of cellular medicines designed to replace or restore…
2+ YOECandidates need a BSc with 2+ years of experience or an MSc in cell biology, biotechnology, biomedical engineering or a related field. Aseptic mammalian cell culture experience, preferably in industry, is required.
Cryopreservation, Good manufacturing practices, Regulatory compliance, Process improvement, Documentation, Biotechnology